期刊文献+

脑胶质瘤术后超选介入化疗联合系统化疗的临床研究 被引量:6

Super-selective interventional chemotherapy combined with systemic chemotherapy for the treatment of postoperative gliomas:a clinical study
下载PDF
导出
摘要 目的探讨术后超选择介入化疗联合系统化疗治疗脑胶质瘤的优势。方法 2006年至2009年山东济宁市第一人民医院介入科收治46例脑胶质瘤的患者,据患者自愿入组的原则分为两组。治疗组:25例患者手术后先行常规放疗,然后行超选介入化疗,同期进行系统化疗。对照组:21例患者手术后先行常规放疗,然后只进行系统化疗。定期随访,复查颅脑CT,测量肿瘤的体积,并进行Karnofsky预后评分。比较肿瘤体积变化及两组间Karnofsky预后评分的差异。结果平均随访2.3年,两组均无死亡病例。化疗前两组肿瘤的体积差异无统计学意义,(P>0.05)。化疗1年后介入化疗联合系统化疗组肿瘤缩小率为67.11%,系统化疗组肿瘤缩小率为45.79%,两组肿瘤体积经独立样本t检验显示肿瘤体积差异有统计学意义(P<0.05)。治疗组在化疗期间出现癫痫3例,眼痛5例,头痛9例,恶心呕吐8例,血小板下降1例。对照组出现癫痫1例,头痛7例,血小板下降3例,恶心呕吐6例。Wilcoxon秩和检验Karnofsky预后评分显示介入化疗结合系统化疗组的预后优于单纯系统化疗组。(P<0.05)。结论术后放疗结合介入化疗联合系统化疗的治疗方法,与术后放疗结合系统化疗的治疗方法相比,可以更有效的控制肿瘤的生长,改善临床症状,提高生活质量,是值得进一步探讨的化疗方法。 Objective To evaluate super-selective interventional chemotherapy combined with systemic chemotherapy in treating postoperative gliomas.Methods During the period of 2005-2009,a total of 46 patients with glioma were encountered in our hospital.According to the principle of patient's free will the involved patients were divided into two groups.Study froup(n = 25):after operation the patients received routine radiotherapy,which was followed by super-selective interventional chemotherapy combined simultaneously with systemic chemotherapy.Control group(n = 21):after operation the patients received routine radiotherapy,which was followed by systemic chemotherapy only.The patients were regularly followed up.Cranial CT checkups were made to determine the tumor size,and the results were evaluated with Karnofsky scores.The clinical data were analyzed and compared between two groups.Results In the study group,the side-effects and complications included epileptic seizures(n = 3),eye pain(n = 5),headache(n = 9),nausea and vomiting(n = 8) and thrombopenia(n = 1).In the control group,the side-effects and complications were as follows:epileptic seizures(n = 1),headache(n = 7),nausea and vomiting(n = 6) and thrombopenia(n = 3).No death occurred in either of the two groups.The patients were followed up for an average period of 2.3 years.Before chemotherapy no statistically significant difference in tumor size existed between two groups(P 0.05).One year after the chemotherapy,the tumor volume in study group was reduced by 67.11%,while it was 45.79% in control group.By using independent sample t test analysis,the difference between two groups was of statistical significance(P 0.05).Wilcoxon rank sum test and Karnofsky prognostic score analysis indicated that the prognosis of study group was much better than that of control group(P 0.05).Conclusion In comparison with routine radiotherapy plus simple systemic chemotherapy,routine radiotherapy plus superselective interventional chemotherapy as well as systemic chemotherapy can more effectively inhibit tumor growth,relieve clinical symptoms and improve living quality.Therefore,it is of clinical value to make a further study of this technique.
出处 《介入放射学杂志》 CSCD 北大核心 2010年第10期817-820,共4页 Journal of Interventional Radiology
关键词 胶质瘤 超选介入化疗 系统化疗 肿瘤体积 glioma super-selective interventional chemotherapy systemic chemotherapy tumor volume
  • 相关文献

参考文献5

  • 1Shaw EG,Tatter SB,Lesser GJ,et al.Current Cont roversies in the radiot herapeutic management of adult low-grade glioma[J].Semin Oncol,2004,31:653-658.
  • 2Stewart LA.Chemotherapy in adult high-gread glioma:a systematic review and meta-analysis of individual patient date from 12 randomised trial[J].Lancet,2002,359:1011-1018.
  • 3吴佩宏.肿瘤介入诊疗学[M].北京:科学出版社,2005:209-210.
  • 4张家涌,那加.超选择颈内动脉卡氮芥化疗致脑组织坏死[J].北京医科大学学报,1998,30(4):358-360. 被引量:3
  • 5Iwadate Y,Namba H,Saegusa T,et al.Intra-arterial mannital infusion inthe chemotherapy for malignant brain tumors[J].J Neurooncol,1993,15:185-193.

共引文献2

同被引文献55

  • 1王明盛,杨正明,陈坚.卡铂、威猛、甲氨蝶呤、尼莫地平联用对脑胶质瘤的抑制作用[J].山东医药,2005,45(10):22-23. 被引量:5
  • 2韩子敏,王巧凤,高福音,任玉川,王玉涛,杨凯军.黄芪川芎嗪注射液加化疗治疗恶性肿瘤36例[J].第四军医大学学报,2006,27(13):1207-1207. 被引量:7
  • 3顾科,张军宁.成人Ⅱ级以上脑胶质瘤术后同步放化疗疗效分析[J].肿瘤防治研究,2007,34(8):626-628. 被引量:13
  • 4Roguin A,Goldstein J,Bar O.Brain tumours among interventional cardiologists:a cause for alarm.report of four new cases from two cities and a review of the literature[J].Euro Intervention,2012,7:1081-1086.
  • 5Saitta L,Heese O,Frster AF,et al.Signal intensity in T2'magnetic resonance imaging is related to brain glioma grade[J].Eur Radiol,2011,21:1068-1076.
  • 6Boockvar JA,Tsiouris AJ,Hofstetter CP,et al.Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma[J].J Neurosurg,2011,114:624-632.
  • 7Briganti C,Sestieri C,Mattei PA,et al.Reorganization of functional connectivity of the language network in patients with brain gliomas[J].American J Neuroradiology,2012,33:1983-1990.
  • 8Burkhardt JK,Riina H,Shin BJ,et al.Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma:progression-free survival and overall survival[J].World Neurosurgery,2012,77:130-134.
  • 9Price SJ,Green HAL,Dean AF,et al.Correlation of MR relative cerebral blood volume measurements with cellular density and proliferation in high-grade gliomas:an image-guided biopsy study[J].American J Neuroradiology,2011,32:501-506.
  • 10江涛,马文斌,杨学军.胶质瘤治疗技术与进展[M].北京:人民卫生出版社,2011:288.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部